Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,604 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Active, Not Recruiting

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

NCT02899052

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham - Main /ID# 151405 Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences /ID# 151399 Little Rock, Arkansas, United States
  • Memorial Healthcare System /ID# 224862 Hollywood, Florida, United States
  • Winship Cancer Institute of Emory University /ID# 161710 Atlanta, Georgia, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib

NCT04790474

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Emek Medical Center Afula, Israel
  • Rambam Medical Center Haifa, Israel
  • Hadassah Ein-Kerem Medical Center Jerusalem, Israel
  • Shearei Zedek Medical Center Jerusalem, Israel
View Trial Details
Active, Not Recruiting

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

NCT05123131

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Beaumont Hospital Dublin, Ireland
  • Mater Misericordiae University Hospital Dublin, Ireland
  • St James's Hospital Dublin, Ireland
View Trial Details
Active, Not Recruiting

Multiple Myeloma Molecular Monitoring Study

NCT03421132

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Active, Not Recruiting

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

NCT04458831

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Arkansas Medical Sciences Site Number : 8400021 Little Rock, Arkansas, United States
  • St. Joseph Heritage Healthcare Site Number : 8400008 Fullerton, California, United States
  • University of California San Francisco (PARENT) Site Number : 8400009 San Francisco, California, United States
  • Holy Cross Hospital Site Number : 8400030 Fort Lauderdale, Florida, United States
View all 129 locations
View Trial Details
Active, Not Recruiting

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

NCT03539744

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407 Tucson, Arizona, United States
  • VA Central California Health Care System /ID# 200047 Fresno, California, United States
  • University of California, Los Angeles /ID# 171524 Los Angeles, California, United States
  • Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 222904 Aurora, Colorado, United States
View all 180 locations
View Trial Details

Related conditions